Bharat (BIBCL) | Financial Analysis & Statements
Bharat Immunologicals & Biologicals Corporation Limited Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2023Income Metrics
Revenue
0
Gross Profit
0
Operating Income
-47.2M
Net Income
-49.2M
EPS (Diluted)
₹-1.14
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
1.1B
Shareholders Equity
787.1M
Debt to Equity
1.39
Cash Flow Metrics
Operating Cash Flow
-708.6M
Free Cash Flow
-456.9M
Revenue & Profitability Trend
Annual Income Flow
2023
Bharat Income Statement From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 446.1M | 783.9M | 853.3M | 668.4M | 836.5M |
| Cost of Goods Sold | 422.1M | 660.5M | 883.5M | 619.2M | 796.9M |
| Gross Profit | 24.0M | 123.4M | -30.2M | 49.2M | 39.6M |
| Gross Margin % | 5.4% | 15.7% | -3.5% | 7.4% | 4.7% |
| Operating Expenses | |||||
| Research & Development | 0 | 5.0K | 4.8M | 5.2M | 5.8M |
| Selling, General & Administrative | 9.9M | 6.5M | 7.0M | 7.3M | 8.4M |
| Other Operating Expenses | 20.8M | 24.8M | 22.2M | 26.5M | 20.8M |
| Total Operating Expenses | 30.7M | 31.3M | 34.0M | 39.0M | 35.0M |
| Operating Income | -160.1M | -48.5M | -211.0M | -105.2M | -94.1M |
| Operating Margin % | -35.9% | -6.2% | -24.7% | -15.7% | -11.3% |
| Non-Operating Items | |||||
| Interest Income | 4.7M | 5.5M | 6.8M | 9.1M | 7.2M |
| Interest Expense | 69.6M | 51.1M | 43.6M | 40.6M | 14.6M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -222.7M | -96.9M | -242.1M | -142.0M | -73.7M |
| Income Tax | -56.3M | -9.3M | -61.0M | -39.9M | -15.8M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -166.4M | -87.5M | -181.1M | -102.1M | -57.9M |
| Net Margin % | -37.3% | -11.2% | -21.2% | -15.3% | -6.9% |
| Key Metrics | |||||
| EBITDA | -154.9M | -40.7M | -202.0M | -99.0M | -56.4M |
| EPS (Basic) | ₹-3.85 | ₹-2.03 | ₹-4.19 | ₹-2.36 | ₹-1.34 |
| EPS (Diluted) | ₹-3.85 | ₹-2.03 | ₹-4.19 | ₹-2.36 | ₹-1.34 |
| Basic Shares Outstanding | 43180000 | 43180000 | 43180000 | 43180000 | 43180000 |
| Diluted Shares Outstanding | 43180000 | 43180000 | 43180000 | 43180000 | 43180000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Bharat Balance Sheet From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 12.9M | 46.4M | 12.3M | 9.8M | 4.1M |
| Short-term Investments | - | - | - | 111.1M | 21.0M |
| Accounts Receivable | 138.8M | 11.3M | 105.0K | 176.1M | 729.7M |
| Inventory | 14.2M | 362.5M | 134.9M | 517.2M | 144.4M |
| Other Current Assets | 53.0K | 40.0K | 31.0K | 30.0K | 106.0K |
| Total Current Assets | 358.0M | 654.3M | 339.5M | 930.2M | 987.4M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 72.0M | 72.0M | 72.0M | 44.7M | 4.6M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 39.0K | -1.0K | - | -1.0K | 2.0K |
| Total Non-Current Assets | 1.5B | 1.5B | 700.3M | 338.1M | 262.2M |
| Total Assets | 1.9B | 2.1B | 1.0B | 1.3B | 1.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 10.3M | 8.7M | 147.9M | 435.3M | 441.8M |
| Short-term Debt | 702.2M | 778.8M | 272.9M | 30.4M | 322.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 27.7M | 28.2M | 5.6M | -2.0K | -1.0K |
| Total Current Liabilities | 940.4M | 1.0B | 640.9M | 1.0B | 884.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | - | - | - |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | -1.0K | 1.0K | -6.0K | - | 1.0K |
| Total Non-Current Liabilities | 63.9M | 61.1M | 58.5M | 56.5M | 58.1M |
| Total Liabilities | 1.0B | 1.1B | 699.4M | 1.1B | 942.8M |
| Equity | |||||
| Common Stock | 431.8M | 431.8M | 431.8M | 431.8M | 431.8M |
| Retained Earnings | -662.1M | -495.7M | -408.2M | -227.1M | -115.0M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 882.1M | 1.1B | 340.4M | 204.7M | 306.8M |
| Key Metrics | |||||
| Total Debt | 702.2M | 778.8M | 272.9M | 30.4M | 322.2M |
| Working Capital | -582.4M | -358.4M | -301.4M | -76.9M | 102.6M |
Balance Sheet Composition
Bharat Cash Flow Statement From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -222.7M | -96.9M | -242.1M | -142.0M | -73.7M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 248.9M | -249.7M | 249.5M | 444.6M | -705.4M |
| Operating Cash Flow | 87.5M | -295.9M | 365.3M | 340.9M | -781.5M |
| Investing Activities | |||||
| Capital Expenditures | 0 | 0 | 0 | -5.0K | -251.0K |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 0 | 1.0K | 1.0K | -4.0K | -251.0K |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | -76.6M | 505.9M | -74.3M | -296.7M | 327.1M |
| Free Cash Flow | 108.9M | -421.2M | 117.8M | 340.8M | -321.2M |
| Net Change in Cash | 10.8M | 210.0M | 291.1M | 44.2M | -454.6M |
Cash Flow Trend
Bharat Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-4.59
Price to Book
0.97
Price to Sales
9.97
PEG Ratio
-0.08
Profitability Ratios
Profit Margin
-241.59%
Operating Margin
-2,888.44%
Return on Equity
-21.00%
Return on Assets
-6.28%
Financial Health
Current Ratio
0.33
Debt to Equity
94.48
Beta
0.34
Per Share Data
EPS (TTM)
₹-3.59
Book Value per Share
₹18.24
Revenue per Share
₹1.77
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BIBCL | 763.0M | -4.59 | 0.97 | -21.00% | -241.59% | 94.48 |
| Biocon | 566.5B | 71.84 | 1.68 | 3.66% | 3.59% | 50.02 |
| OneSource Specialty | 202.8B | 936.63 | 3.11 | -0.31% | 1.42% | 21.93 |
| Zota Health Care | 39.4B | -62.53 | 12.61 | -24.83% | -15.37% | 56.90 |
| Dishman Carbogen | 26.5B | 22.30 | 0.42 | 0.06% | 4.25% | 40.20 |
| Panacea Biotec | 21.8B | 182.62 | 2.65 | -1.01% | -1.29% | 2.79 |
Financial data is updated regularly. All figures are in the company's reporting currency.




